| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8221134 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 8 Pages |
Abstract
HDR multicatheter interstitial brachytherapy was well tolerated, with no significant detrimental effect on measured QOL scales/items through 2 years of follow-up. Compared to pretreatment scores, there was improvement in breast symptoms, emotional functioning, social functioning, and future perspective 2 years after treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Adam A. MD, Daniel J. MD, PhD, Todd A. PhD, Teresa L. PhD, Julie A. MD, Amy E. MD, Michael MD, Rebecca MD, PhD, William E. MD, Timothy MD, Melissa A. BSN, RN, Laura L. ANP, PhD, Imran MD,